FP-1201

· Faron Pharmaceuticals Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FP-1201, covering 2015-05-27 to 2015-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II [Phase 1, Phase 2]